These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
63. MRI-guided single fraction ablative radiotherapy for early-stage breast cancer: a brachytherapy versus volumetric modulated arc therapy dosimetry study. Charaghvandi RK; den Hartogh MD; van Ommen AM; de Vries WJ; Scholten V; Moerland MA; Philippens ME; Schokker RI; van Vulpen M; van Asselen B; van den Bongard DH Radiother Oncol; 2015 Dec; 117(3):477-82. PubMed ID: 26438972 [TBL] [Abstract][Full Text] [Related]
64. A treatment planning comparison of photon stereotactic ablative radiotherapy and proton beam therapy for the re-irradiation of pelvic cancer recurrence. Chuter R; Glassborow E; Speight R; Clarke M; Murray L; Radhakrishna G; Lavin V; Aspin L; Aldred M; Gregory S; Richardson J; Handley J Phys Imaging Radiat Oncol; 2022 Jan; 21():78-83. PubMed ID: 35243036 [TBL] [Abstract][Full Text] [Related]
65. Identifying predictors of on-table adaptation for pancreas stereotactic body radiotherapy (SBRT). Wu TC; Yoon SM; Cao M; Raldow AC; Xiang M Clin Transl Radiat Oncol; 2023 May; 40():100603. PubMed ID: 36896266 [TBL] [Abstract][Full Text] [Related]
66. Dosimetric effects of the prone and supine positions on image guided localized prostate cancer radiotherapy. Liu B; Lerma FA; Patel S; Amin P; Feng Y; Yi BY; Yu C Radiother Oncol; 2008 Jul; 88(1):67-76. PubMed ID: 18207595 [TBL] [Abstract][Full Text] [Related]
68. Evaluation of sparing organs at risk (OARs) in left-breast irradiation in the supine and prone positions and with deep inspiration breath-hold. Saini AS; Hwang CS; Biagioli MC; Das IJ J Appl Clin Med Phys; 2018 Jul; 19(4):195-204. PubMed ID: 29927027 [TBL] [Abstract][Full Text] [Related]
69. Whole abdominopelvic radiotherapy (WAPRT) using intensity-modulated arc therapy (IMAT): first clinical experience. Duthoy W; De Gersem W; Vergote K; Coghe M; Boterberg T; De Deene Y; De Wagter C; Van Belle S; De Neve W Int J Radiat Oncol Biol Phys; 2003 Nov; 57(4):1019-32. PubMed ID: 14575833 [TBL] [Abstract][Full Text] [Related]
70. Can Polymetastatic Disease Be ARRESTed Using SABR? A Dosimetric Feasibility Study to Inform Development of a Phase 1 Trial. Corkum MT; Fakir H; Palma DA; Nguyen T; Bauman GS Adv Radiat Oncol; 2021; 6(5):100734. PubMed ID: 34278053 [TBL] [Abstract][Full Text] [Related]
71. Dosimetric comparison of MR-linac-based IMRT and conventional VMAT treatment plans for prostate cancer. Da Silva Mendes V; Nierer L; Li M; Corradini S; Reiner M; Kamp F; Niyazi M; Kurz C; Landry G; Belka C Radiat Oncol; 2021 Jul; 16(1):133. PubMed ID: 34289868 [TBL] [Abstract][Full Text] [Related]
72. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord. Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826 [TBL] [Abstract][Full Text] [Related]
73. Case Report: First in Human Online Adaptive MR Guided SBRT of Peritoneal Carcinomatosis Nodules: A New Therapeutic Approach for the Oligo-Metastatic Patient. Boldrini L; Romano A; Placidi L; Mattiucci GC; Chiloiro G; Cusumano D; Pollutri V; Antonelli MV; Indovina L; Gambacorta MA; Valentini V Front Oncol; 2020; 10():601739. PubMed ID: 33384958 [TBL] [Abstract][Full Text] [Related]
74. Dose-escalated volumetric modulated arc therapy for total marrow irradiation: A feasibility dosimetric study with 4DCT planning and simultaneous integrated boost. Jaccard M; Lamanna G; Kountouri M; Rouzaud M; Miralbell R; Zilli T Phys Med; 2020 Oct; 78():123-128. PubMed ID: 33002733 [TBL] [Abstract][Full Text] [Related]
75. On-line adaptive MR guided radiotherapy for locally advanced pancreatic cancer: Clinical and dosimetric considerations. Placidi L; Romano A; Chiloiro G; Cusumano D; Boldrini L; Cellini F; Mattiucci GC; Valentini V Tech Innov Patient Support Radiat Oncol; 2020 Sep; 15():15-21. PubMed ID: 32642565 [TBL] [Abstract][Full Text] [Related]
76. The effect of planning algorithms in oesophageal radiotherapy in the context of the SCOPE 1 trial. Wills L; Millin A; Paterson J; Crosby T; Staffurth J Radiother Oncol; 2009 Dec; 93(3):462-7. PubMed ID: 19782420 [TBL] [Abstract][Full Text] [Related]
77. Partial stereotactic ablative boost radiotherapy in bulky non-small cell lung cancer: a retrospective study. Bai Y; Gao XS; Qin SB; Chen JY; Su MM; Liu Q; Qin XB; Ma MW; Zhao B; Gu XB; Xie M; Cui M; Qi X; Li XY Onco Targets Ther; 2018; 11():2571-2579. PubMed ID: 29780250 [TBL] [Abstract][Full Text] [Related]
78. Functional lung avoidance and response-adaptive escalation (FLARE) RT: Multimodality plan dosimetry of a precision radiation oncology strategy. Lee E; Zeng J; Miyaoka RS; Saini J; Kinahan PE; Sandison GA; Wong T; Vesselle HJ; Rengan R; Bowen SR Med Phys; 2017 Jul; 44(7):3418-3429. PubMed ID: 28453861 [TBL] [Abstract][Full Text] [Related]
79. Improved VMAT planning for head and neck tumors with an advanced optimization algorithm. Klippel N; Schmücking M; Terribilini D; Geretschläger A; Aebersold DM; Manser P Z Med Phys; 2015 Dec; 25(4):333-340. PubMed ID: 26071076 [TBL] [Abstract][Full Text] [Related]
80. Impact of abdominal compression on intra-fractional motion and delivered dose in magnetic resonance image-guided adaptive radiation ablation of adrenal gland metastases. Bernchou U; Schytte T; Bertelsen A; Lorenzen EL; Brink C; Mahmood F Phys Med; 2023 Oct; 114():102682. PubMed ID: 37717398 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]